Innovating Works

Nosopharm

Desconocido
GNA NOW: NOVEL GRAM NEGATIVE ANTIBIOTIC NOW Nosopharm SAS participó en un H2020: H2020-JTI-IMI2-2018-16-single-stage AntiMicrobial Resistance (AMR) is a global and serious threat to human health. Gram-negative bacteria are widely regarded as the culprit rep...
2019-06-17 - 2025-12-31 | Financiado
ENABLE: European Gram Negative Antibacterial Engine Nosopharm SAS participó en un FP6: The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens...
2014-02-01 - 2020-01-31 | Financiado
ENABLE: European Gram Negative Antibacterial Engine Nosopharm SAS participó en un FP7: The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.